INVESTIGATION OF INCREASED LEVELS OF ANXIETY AND DEPRESSION IMPACT ON THE QUALITY OF LIFE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME

Authors:

Abstract:

The purpose of the study was to determine the effect of elevated levels of anxiety and depression on the quality of life of patients with irritable bowel syndrome depending on the frequency of exacerbations of the disease. The study included 72 patients aged 18 to 67 years with a clinically confirmed diagnosis of irritable bowel syndrome. Patients were stratified into three groups according to the frequency of exacerbations: rare (group A), moderate (group B) and frequent (group C). The study included an assessment of quality of life using the SF-36 questionnaire, depression level using the Beck Depression Inventory and anxiety level using the GAD-7 scale. The results showed a significant decrease in all quality of life indicators in patients with frequent exacerbations of irritable bowel syndrome, especially on the scales of physical functioning, vital activity, mental health, and social functioning. At the same time, a statistically significant increase in Beck Depression Inventory and GAD-7 scores was noted in these groups, indicating a high level of emotional distress. Correlation analysis confirmed a close inverse relationship between anxiety/depression indicators and quality of life scales. The results obtained emphasise the need for a biopsychosocial approach to the treatment of patients with irritable bowel syndrome with mandatory screening of emotional state and the use of psycho-emotional support as a supplement to gastroenterological therapy. The introduction of multidisciplinary support improves quality of life, reduces the frequency of relapses and increases the effectiveness of treatment.

Keywords:

irritable bowel syndrome quality of life anxiety disorders depression SF-36 psychoemotional state

References:

1. Al Dosari MN, Alotaibi RM, Algahtani MN, Alshammari TS, Almziri BF. Assessing the Impact of Irritable Bowel Syndrome on Quality of Life in Patients at Family Medicine and Primary Health Care Clinics of the National Guard Health Affairs, Riyadh. Cureus. 2024; 16(12): 76158. doi: 10.7759/cureus.76158.
2. Bie F, Yan X, Xing J, Wang L, Xu Y, Wang G. et al. Rising global burden of anxiety disorders among adolescents and young adults: trends, risk factors, and the impact of socioeconomic disparities and COVID-19 from 1990 to 2021. Front Psychiatry. 2024; 15: 1489427. doi: 10.3389/fpsyt.2024.1489427.
3. Edebol-Carlman H, Schrooten M, Ljótsson B, Boersma K, Linton S, Brummer RJ. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial. Scand J Pain. 2018; 18(1) :81-91. doi: 10.1515/sjpain-2017-0153.
4. Hu P, Liu J, Maita I, Kwok C, Gu E, Gergues MM. et al. Chronic Stress Induces Maladaptive Behaviors by Activating Corticotropin-Releasing Hormone Signaling in the Mouse Oval Bed Nucleus of the Stria Terminalis. J Neurosci. 2020; 40(12): 2519-2537. doi: 10.1523/JNEUROSCI.2410-19.2020.
5. Kenwood MM, Kalin NH, Barbas H. The prefrontal cortex, pathological anxiety, and anxiety disorders. Neuropsychopharmacoly. 2022; 47 (1): 260-275. doi: 10.1038/s41386-021-01109-z.
6. Ma S, Yang J, Yang B, Kang L, Wang P, Zhang N. et al. The Patient Health Questionnaire-9 vs. the Hamilton Rating Scale for Depression in Assessing Major Depressive Disorder. Front Psychiatry. 2021; 12: 747139. doi: 10.3389/fpsyt.2021.747139.
7. Marano G, Traversi G, Pola R, Gasbarrini A, Gaetani E, Mazza M. Irritable Bowel Syndrome: A Hallmark of Psychological Distress in Women? Life. 2025; 15(2): 277. doi: 10.3390/life15020277.
8. Mofatteh M. Risk factors associated with stress, anxiety, and depression among university undergraduate students. AIMS Public Health. 2020; 8(1): 36-65. doi: 10.3934/publichealth.2021004.
9. Möller HJ, Bandelow B, Volz HP, Barnikol UB, Seifritz E, Kasper S. The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice. Eur Arch Psychiatry Clin Neurosci. 2016; 266 (8): 725-736. doi: 10.1007/s00406-016-0684-7.
10. Orsolini L, Latini R, Pompili M, Serafini G, Volpe U, Vellante F. et al. Understanding the Complex of Suicide in Depression: from Research to Clinics. Psychiatry Investig. 2020; 17 (3): 207-221. doi: 10.30773/pi.2019.0171.
11. Person H, Keefer L. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis. Prog Neuropsychopharmacol Biol Psychiatry. 2021; 107: 110209. doi: 10.1016/j.pnpbp.2020.110209.
12. Rathore K, Shukla N, Naik S, Sambhav K, Dange K, Bhuyan D. et al. The Bidirectional Relationship Between the Gut Microbiome and Mental Health: A Comprehensive Review. Cureus. 2025; 17 (3): 80810. doi: 10.7759/cureus.80810.
13. Staudacher HM, Black CJ, Teasdale SB, Mikocka-Walus A, Keefer L. Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management. Nat Rev Gastroenterol Hepatol. 2023; 20 (9): 582-596. doi: 10.1038/s41575-023-00794-z.
14. Vastyanov RS, Stoyanov OM, Platonova OM, Yermuraki PP, Ostapenko IO, Tatarko SV. et al. Pathogenetic mechanisms of convulsive depressive syndrome in conditions of kindling model of epileptogenesis. World of Medicine and Biology. 2021; 1 (75): 181-186. doi: 10.26724/2079-8334-2021-1-75-181-186.
15. Wu C, Mu Q, Gao W, Lu S. The characteristics of anhedonia in depression: a review from a clinically oriented perspective. Transl Psychiatry. 2025; 15(1): 90. doi: 10.1038/s41398-025-03310-w.

Publication:

«World of Medicine and Biology» Vol. 21 No. 92 (2025) , с. 89-94
УДК 616.34-008.711.1-009:616.8-008.64-06

DOI:

https://doi.org/10.26724/2079-8334-2025-2-92-89-94